ES2052478T1 - Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos. - Google Patents

Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos.

Info

Publication number
ES2052478T1
ES2052478T1 ES91900526T ES91900526T ES2052478T1 ES 2052478 T1 ES2052478 T1 ES 2052478T1 ES 91900526 T ES91900526 T ES 91900526T ES 91900526 T ES91900526 T ES 91900526T ES 2052478 T1 ES2052478 T1 ES 2052478T1
Authority
ES
Spain
Prior art keywords
hiv
particles
recombinants
reproduction
possibility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
ES91900526T
Other languages
English (en)
Spanish (es)
Inventor
Omar K Haffar
Shiu-Lok Hu
Allen W Senear
Bruce M Travis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of ES2052478T1 publication Critical patent/ES2052478T1/es
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES91900526T 1989-11-20 1990-11-20 Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos. Pending ES2052478T1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43920589A 1989-11-20 1989-11-20

Publications (1)

Publication Number Publication Date
ES2052478T1 true ES2052478T1 (es) 1994-07-16

Family

ID=23743729

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900526T Pending ES2052478T1 (es) 1989-11-20 1990-11-20 Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos.

Country Status (14)

Country Link
EP (1) EP0502105A4 (cs)
JP (1) JPH05503629A (cs)
KR (1) KR920703639A (cs)
AU (1) AU636944B2 (cs)
CA (1) CA2068713A1 (cs)
ES (1) ES2052478T1 (cs)
FI (1) FI922277A7 (cs)
GR (1) GR930300005T1 (cs)
HU (1) HUT60506A (cs)
NO (1) NO921969L (cs)
OA (1) OA09698A (cs)
TW (1) TW216446B (cs)
WO (1) WO1991007425A1 (cs)
ZA (1) ZA909302B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0431128B1 (en) * 1989-06-01 2003-03-26 Applied Biotechnology, Inc. Vector coding for self-assembled, defective, non-self-propagating viral particles
US5861282A (en) * 1989-10-16 1999-01-19 Whitehead Institute For Biomedical Research Non-infectious HIV particles and uses therefor
WO1991019803A1 (en) * 1990-06-19 1991-12-26 Applied Biotechnology, Incorporated Self assembled, defective, nonself-propagating viral particles
DE4124817A1 (de) * 1991-07-26 1993-01-28 Basf Ag Waessrige polymerisatdispersionen
DE69232650T2 (de) * 1991-11-08 2002-11-28 Pharmacia & Upjohn Co., Kalamazoo Vakzine gegen katzenleukämievirus
CA2118026A1 (en) * 1992-04-14 1993-10-28 Guy T. Layton Induction of ctl responses
EP1473369B1 (en) 1993-01-26 2009-01-07 The Trustees of the University of Pennsylvania (a corporation of Pennsylvania) Compositions and methods for delivery of genetic material
US7001759B1 (en) 1993-01-26 2006-02-21 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
ES2249760T3 (es) 1993-01-26 2006-04-01 The Trustees Of The University Of Pennsylvania (A Corporation Of Pennsylvania) Composiciones y procedimientos de administracion de materias geneticas.
GB9304239D0 (en) * 1993-03-01 1993-04-21 British Bio Technology Viral particles
US6291157B1 (en) 1998-02-23 2001-09-18 Connaught Laboratories Limited Antigenically-marked non-infectious retrovirus-like particles
US5955342A (en) * 1994-08-15 1999-09-21 Connaught Laboratories Limited Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
US5858838A (en) 1998-02-23 1999-01-12 Taiwan Semiconductor Manufacturing Company, Ltd. Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate
US6080408A (en) 1994-08-22 2000-06-27 Connaught Laboratories Limited Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
WO1996030523A2 (en) * 1995-03-31 1996-10-03 Hans Wolf Antigen presentation system based on retrovirus-like particles
US6013506A (en) * 1995-06-05 2000-01-11 Wardley; Richard C. Feline leukemia virus vaccines
US6121021A (en) * 1997-12-16 2000-09-19 Connaught Laboratories Limited Constitutive expression of non-infectious HIV-like particles
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
CA2401974C (en) 2000-03-02 2013-07-02 Emory University Dna expression vectors and methods of use
EP1372710B1 (en) * 2001-03-08 2009-10-14 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Mva expressing modified hiv envelope, gag, and pol genes
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AU2012238351B2 (en) 2011-04-06 2016-11-24 Biovaxim Limited Pharmaceutical compositions for preventing and/or treating an HIV disease in humans
ES2937963T3 (es) 2015-07-21 2023-04-03 Modernatx Inc Vacunas de enfermedad infecciosa
WO2018170256A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Herpes simplex virus vaccine
WO2018170270A1 (en) 2017-03-15 2018-09-20 Modernatx, Inc. Varicella zoster virus (vzv) vaccine
US12070495B2 (en) 2019-03-15 2024-08-27 Modernatx, Inc. HIV RNA vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752565A (en) * 1986-04-07 1988-06-21 The United States Of America As Represented By The Department Of Health And Human Services Cell line producing AIDS viral antigens without producing infectious virus particles
JPH02203783A (ja) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd 抗原性を有する非感染性エイズウイルス産生クローン化ヒトｔ細胞
JP3140757B2 (ja) * 1989-02-06 2001-03-05 デイナ・フアーバー・キヤンサー・インステイテユート パッケージング欠陥ｈｉｖプロウイルス、細胞系及びその使用
GB8923123D0 (en) * 1989-10-13 1989-11-29 Connaught Lab A vaccine for human immunodeficiency virus
CA2067778A1 (en) * 1989-10-16 1991-04-17 The Whitehead Institute For Biomedical Research Non-infectious hiv-1 particles and uses therefor

Also Published As

Publication number Publication date
AU6905591A (en) 1991-06-13
EP0502105A1 (en) 1992-09-09
HU9201659D0 (en) 1992-08-28
NO921969L (no) 1992-06-26
EP0502105A4 (en) 1993-02-24
HUT60506A (en) 1992-09-28
CA2068713A1 (en) 1991-05-21
AU636944B2 (en) 1993-05-13
FI922277A0 (fi) 1992-05-19
JPH05503629A (ja) 1993-06-17
FI922277A7 (fi) 1992-05-19
OA09698A (en) 1993-08-30
KR920703639A (ko) 1992-12-18
ZA909302B (en) 1991-09-25
GR930300005T1 (cs) 1993-04-28
WO1991007425A1 (en) 1991-05-30
TW216446B (cs) 1993-11-21
NO921969D0 (no) 1992-05-19

Similar Documents

Publication Publication Date Title
ES2052478T1 (es) Particulas retrovirales no replicantes producidas de forma recombinante empleadas como agentes antivirales e inmunogenos.
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
Karacostas et al. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
ATE174960T1 (de) Rekombinante retroviren
ES2150897T3 (es) Procedimiento de fabricacion recombinante de las proteinas derivadas de hiv-2 y cultivo celular que expresa proteinas de hiv-2.
DK513388D0 (da) Peptider med immunologiske egenskaber svarende til hiv-2 virus, nucleotidsekvenser, der koder for saadanne peptider, antigene og immunogene midler indeholdende saadanne peptider samt fremgangsmaade og kit til in vitro diagnose af hiv-2
WO1991002805A3 (en) Recombinant retroviruses delivering vector constructs to target cells
Weger-Lucarelli et al. A novel MVA vectored Chikungunya virus vaccine elicits protective immunity in mice
ES2052368T3 (es) Factores sanguineos producidos por recombinacion y el proceso para la expresion de dichos factores, asi como recombinacion del virus de vaccina usados en dicho proceso.
Diagne et al. Vector competence of Aedes aegypti and Aedes vittatus (Diptera: Culicidae) from Senegal and Cape Verde archipelago for West African lineages of chikungunya virus
DE3850683D1 (de) Hybrides RNS-Virus.
ES2070997T3 (es) Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
AR003425A1 (es) Poxvirus recombinante de mapache, vacuna para uso en gatos y uso de poxvirus para preparar una vacuna util para evitar o para disminuir la enfermedad causada por el virus de inmunodeficiencia felina (fiv)
ES2087055T3 (es) Proteccion de plantas contra infeccion virica.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
SE9102974L (sv) Adenovira och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
ES2056565T3 (es) Virus recombinante de la enfermedad de marek.
ES2115622T3 (es) Clones moleculares de hiv-1 y usos de los mismos.
ES2061603T3 (es) Mutantes viricos de la rinotraqueitis bovina infecciosa, vacunas que los contienen, metodos para la produccion de los mismos y metodos para el empleo de los mismos.
MY104530A (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses.
ES2399875T3 (es) Composiciones de vacunas de ADN y procedimientos para su uso
ES2062990T3 (es) Vacunas, que contienen la proteina f del virus del sida.
Schiff et al. The pathophysiology of murine retrovirus-induced leukemias
ES2058116T3 (es) El virus varicella-zoster como una vacuna recombinante viva.
DK631387D0 (da) Virusvektor